We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 13, 2022

Effectiveness of Cladribine Tablets vs Other Oral Disease-Modifying Treatments for MS

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Mult. Scler. 2022 Nov 26;[EPub Ahead of Print], T Spelman, S Ozakbas, R Alroughani, M Terzi, S Hodgkinson, G Laureys, T Kalincik, A Van Der Walt, B Yamout, J Lechner-Scott, A Soysal, J Kuhle, JL Sanchez-Menoyo, Y Blanco Morgado, D Spitaleri, V van Pesch, D Horakova, R Ampapa, F Patti, R Macdonell, A Al-Asmi, O Gerlach, J Oh, A Altintas, N Tundia, SL Wong, H Butzkueven

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading